Page 52 - EndoProxy2012_final

endo | 100 Endo Boulevard | Chadds Ford, Pennsylvania 19317 46
(o) The business address for this person is c/o Endo Pharmaceuticals Holdings Inc., 100 Endo Boulevard, Chadds
Ford, Pennsylvania 19317.
(p) The business address for this entity is 333 South Hope Street, Los Angeles, CA 90071. This ownership information
is based on a Schedule 13G/A filed with the SEC on February 14, 2012 by Capital Research Global Investors.
(q) The business address for this entity is 151 Detroit Street, Denver, Colorado 80206. This ownership information is
based on a Schedule 13G filed with the SEC on February 14, 2012 by Janus Capital Management.
(r) The business address for this entity is 40 East 52nd Street, New York, NY 10022. This ownership information is
based on a Schedule 13G/A filed with the SEC on February 13, 2012 by BlackRock, Inc.
(s) The business address for this entity is 82 Devonshire Street, Boston, Massachusetts, 02109. This ownership infor-
mation is based on a Schedule 13G/A filed with the SEC on February 14, 2012 by FMR LLC.
(t) The business address for this entity is 155 N. Wacker Drive, Suite 4600, Chicago, IL 60606. This ownership infor-
mation is based on a Schedule 13G filed with the SEC on February 9, 2011 by LSV Asset Management.
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Securities Exchange Act of 1934 requires our executive officers, directors and greater-than-ten-per-
cent stockholders (collectively, Reporting Persons) to file an initial report of ownership (Form 3) and reports of changes of
ownership (Forms 4 and 5) of Endo securities with the SEC and the NASDAQ. These persons are also required to furnish
the Company with copies of all Section 16(a) reports that they file with respect to Endo securities. Based solely upon a re-
view of Section 16(a) reports furnished to the Company for the year ended December 31, 2011 and written representations
from certain Reporting Persons that no other reports were required, the Company believes that all the Reporting Persons
complied with all applicable filing requirements for the year ended December 31, 2011, except that one transaction by Mr.
Scodari was not filed on a timely basis (one day late) due to a Company administrative error. This report was subsequently
filed.
The corporate action described in this Proxy Statement will not afford stockholders the opportunity to dissent from the
actions described herein or to receive an agreed or judicially appraised value for their shares.
As of the date of this Proxy Statement, the Board of Directors of the Company knows of no other matters to be presented
for stockholder action at the Annual Meeting. However, other matters may properly come before the Annual Meeting or any
adjournment or postponement thereof. If any other matter is properly brought before the Annual Meeting for action by the
stockholders, proxies in the enclosed form returned to the Company will be voted in accordance with the recommendation
of the Board of Directors.
No Dissenters’ Rights
Other Matters
The Company’s 2011 Annual Report to its stockholders is being mailed to all stockholders concurrently with this Proxy
Statement. Copies of the Company’s Form 10-K as filed with the SEC and any amendments thereto may be obtained with-
out charge by writing to Endo, 100 Endo Boulevard, Chadds Ford, Pennsylvania 19317, Attention: Secretary.
Annual Report/Form 10-K